BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31304523)

  • 1. Prevalence survey of healthcare-associated infections in a large teaching hospital.
    Barbato D; Castellani F; Angelozzi A; Isonne C; Baccolini V; Migliara G; Marzuillo C; De Vito C; Villari P; Romano F; De Giusti M
    Ann Ig; 2019; 31(5):423-435. PubMed ID: 31304523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Healthcare-associated infections and antimicrobial use in acute care hospitals: a point prevalence survey in Lombardy, Italy, in 2022.
    Antonelli A; Ales ME; Chiecca G; Dalla Valle Z; De Ponti E; Cereda D; Crottogini L; Renzi C; Signorelli C; Moro M
    BMC Infect Dis; 2024 Jun; 24(1):632. PubMed ID: 38918691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use.
    Zarb P; Coignard B; Griskeviciene J; Muller A; Vankerckhoven V; Weist K; Goossens M; Vaerenberg S; Hopkins S; Catry B; Monnet D; Goossens H; Suetens C; ;
    Euro Surveill; 2012 Nov; 17(46):. PubMed ID: 23171822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 2-year point-prevalence surveillance of healthcare-associated infections and antimicrobial use in Ferrara University Hospital, Italy.
    Antonioli P; Bolognesi N; Valpiani G; Morotti C; Bernardini D; Bravi F; Di Ruscio E; Stefanati A; Gabutti G
    BMC Infect Dis; 2020 Jan; 20(1):75. PubMed ID: 31973704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burden of Six Healthcare-Associated Infections on European Population Health: Estimating Incidence-Based Disability-Adjusted Life Years through a Population Prevalence-Based Modelling Study.
    Cassini A; Plachouras D; Eckmanns T; Abu Sin M; Blank HP; Ducomble T; Haller S; Harder T; Klingeberg A; Sixtensson M; Velasco E; Weiß B; Kramarz P; Monnet DL; Kretzschmar ME; Suetens C
    PLoS Med; 2016 Oct; 13(10):e1002150. PubMed ID: 27755545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for healthcare-associated infection in light of two years of experience with the ECDC point prevalence survey of healthcare-associated infection and antimicrobial use in Poland.
    Deptuła A; Trejnowska E; Ozorowski T; Hryniewicz W
    J Hosp Infect; 2015 Aug; 90(4):310-5. PubMed ID: 25933918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healthcare-associated pneumonia in acute care hospitals in European Union/European Economic Area countries: an analysis of data from a point prevalence survey, 2011 to 2012.
    Walter J; Haller S; Quinten C; Kärki T; Zacher B; Eckmanns T; Abu Sin M; Plachouras D; Kinross P; Suetens C;
    Euro Surveill; 2018 Aug; 23(32):. PubMed ID: 30107871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Point prevalence of healthcare-associated infections and antibiotic use in three large Swiss acute-care hospitals.
    Metsini A; Vazquez M; Sommerstein R; Marschall J; Voide C; Troillet N; Gardiol C; Pittet D; Zingg W; The Swissnoso Network
    Swiss Med Wkly; 2018; 148():w14617. PubMed ID: 29698542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Point prevalence survey of antimicrobial use and healthcare-associated infections in Belgian acute care hospitals: results of the Global-PPS and ECDC-PPS 2017.
    Vandael E; Latour K; Goossens H; Magerman K; Drapier N; Catry B; Versporten A;
    Antimicrob Resist Infect Control; 2020; 9(1):13. PubMed ID: 31956402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of healthcare-associated infections in acute care hospitals in Jacksonville, Florida.
    Magill SS; Hellinger W; Cohen J; Kay R; Bailey C; Boland B; Carey D; de Guzman J; Dominguez K; Edwards J; Goraczewski L; Horan T; Miller M; Phelps M; Saltford R; Seibert J; Smith B; Starling P; Viergutz B; Walsh K; Rathore M; Guzman N; Fridkin S
    Infect Control Hosp Epidemiol; 2012 Mar; 33(3):283-91. PubMed ID: 22314066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of healthcare-associated infections and antimicrobial use among inpatients in a tertiary hospital in Fiji: a point prevalence survey.
    Loftus MJ; Curtis SJ; Naidu R; Cheng AC; Jenney AWJ; Mitchell BG; Russo PL; Rafai E; Peleg AY; Stewardson AJ
    Antimicrob Resist Infect Control; 2020 Aug; 9(1):146. PubMed ID: 32859255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Point prevalence surveys on healthcare acquired infections in medical and surgical wards of a teaching hospital in Rome.
    Marani A; Napoli C; Berdini S; Montesano M; Ferretti F; Di Ninno F; Orioli R; De Luca A; Sommella L; Tarsitani G; Orsi GB
    Ann Ig; 2016; 28(4):274-81. PubMed ID: 27479763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimodal surveillance of healthcare associated infections in an intensive care unit of a large teaching hospital.
    Migliara G; Di Paolo C; Barbato D; Baccolini V; Salerno C; Nardi A; Alessandri F; Giordano A; Tufi D; Marinelli L; Cottarelli A; De Giusti M; Marzuillo C; De Vito C; Antonelli G; Venditti M; Tellan G; Ranieri MV; Villari P
    Ann Ig; 2019; 31(5):399-413. PubMed ID: 31304521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Point-prevalence survey of hospital acquired infections in three acute care hospitals in Northern Nigeria.
    Abubakar U
    Antimicrob Resist Infect Control; 2020 May; 9(1):63. PubMed ID: 32393348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors and medical costs for healthcare-associated carbapenem-resistant Escherichia coli infection among hospitalized patients in a Chinese teaching hospital.
    Meng X; Liu S; Duan J; Huang X; Zhou P; Xiong X; Gong R; Zhang Y; Liu Y; Fu C; Li C; Wu A
    BMC Infect Dis; 2017 Jan; 17(1):82. PubMed ID: 28095785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring healthcare-associated infections and antimicrobial use at regional level through repeated point prevalence surveys: what can be learnt?
    Arnoldo L; Smaniotto C; Celotto D; Brunelli L; Cocconi R; Tignonsini D; Faruzzo A; Brusaferro S;
    J Hosp Infect; 2019 Apr; 101(4):447-454. PubMed ID: 30597175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Point prevalence and risk factors of hospital acquired infections in a cluster of university-affiliated hospitals in Shiraz, Iran.
    Askarian M; Yadollahi M; Assadian O
    J Infect Public Health; 2012 Apr; 5(2):169-76. PubMed ID: 22541264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healthcare-associated infections and antimicrobial use in acute care hospitals in Greece, 2022; results of the third point prevalence survey.
    Palaiopanos K; Krystallaki D; Mellou K; Kotoulas P; Kavakioti CA; Vorre S; Vertsioti G; Gkova M; Maragkos A; Tryfinopoulou K; Paraskevis D; Tsiodras S; Zaoutis T
    Antimicrob Resist Infect Control; 2024 Jan; 13(1):11. PubMed ID: 38273402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence study on health-care associated infections and on the use of antimicrobials carried out with the light protocol of the European Centre for Disease Prevention and Control.
    Gugliotta C; Deiana G; Dettori M; Sotgiu G; Azara A; Castiglia P
    Ann Ig; 2020; 32(4):357-367. PubMed ID: 32744294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of a new methodology and R package reveals a high burden of healthcare-associated infections (HAI) in Germany compared to the average in the European Union/European Economic Area, 2011 to 2012.
    Zacher B; Haller S; Willrich N; Walter J; Abu Sin M; Cassini A; Plachouras D; Suetens C; Behnke M; Gastmeier P; Wieler LH; Eckmanns T
    Euro Surveill; 2019 Nov; 24(46):. PubMed ID: 31771703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.